A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
I-Mab Biopharma US Limited
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
SOLTI Breast Cancer Research Group
Novartis
Zhejiang Provincial People's Hospital
TJ Biopharma Co., Ltd.